Most Cited
| Year | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of Published Articles | 238 | 477 | 760 | 633 | 701 | 653 | 622 | 660 | 700 | 706 | 6150 |
| Citations | 2271 | 4232 | 4990 | 2871 | 2238 | 1793 | 1256 | 1045 | 629 | 161 | 21486 |
| Article published in 2015 and 2016: 1275, Citation in 2017 to articles Published in 2015 and 2016- 3049 Projected Impact Factor (2017): 3049/1275 = 2.391 Article published in 2016 and 2017: 1282, Citation in 2018 to articles Published in 2016 and 2017- 2104 Projected Impact Factor (2018): 2104/1282 = 1.641 Article published in 2017 and 2018: 1360, Citation in 2019 to articles Published in 2017 and 2018- 1674 Projected Impact Factor (2019): 1674/1360 = 1.230 |
|||||||||||
A STUDY COMPARING RESCUE MEDICATIONS: ARFORMOTEROL AND SALBUTAMOL NEBULIZATION IN EXACERBATION OF NON-SEVERE ASTHMA AT A TERTIARY CARE CENTER, NOT NEEDING HOSPITALIZATION
Objectives: Arformoterol is the (R, R) - enantiomer of formoterol, a short and long acting β-2 agonist bronchodilator and is distinguishable from the racemic (R, R/S,S) - diasteriomer of formoterol, which is most commonly used. Some in vitro data show significant bronchodilatation, inhibition of inflammation and marked baseline airway reversibility with arformoterol. Yet, there is a dearth of stu...
2049
709
SOLUBILITY ENHANCEMENT AND DEVELOPMENT OF DISPERSIBLE TABLET OF CANDESARTAN CILEXITIL
Candesartan Cilexitil is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. Candesartan cilexitil is a BCS class II drug having low solubility and high permeability. Candesartan Cilexitil is a prodrug which is rapidly converted to the active drug, Candesartan, by ester hydrolysis during absorption from the gastrointestinal tract. The bioavailability of Candesartan...
2181
678
MAPPING OF NATURAL KAPOSI SARCOMA INHIBITOR USING NETWORK BIOLOGY APPROACH
Identification of protein-ligand interactionnetworks on a proteome scale is crucial to address a wide range of biological problems such as correlating molecular functions to physiological processes and designing safe and efficient therapeutics. In this study we have developed a novel computational strategy to identify ligand binding profiles of proteins across gene families and applied it to predi...
1626
625